Yes, you can take birth control during the transition to menopause, and many women do. Combined birth control pills, progestin-only pills, and hormonal IUDs are all used during perimenopause for two purposes: preventing pregnancy and managing symptoms like hot flashes, irregular periods, and heavy bleeding. Both ACOG and the North American Menopause Society recommend continuing contraception until menopause is confirmed or until age 50 to 55.
The key distinction here is timing. Perimenopause, the years leading up to your final period, is when birth control is most useful. Once you’ve reached menopause (12 consecutive months without a period), birth control is no longer necessary, and most women transition to lower-dose hormone therapy if they still need symptom relief.
Why You Still Need Contraception in Perimenopause
Fertility drops significantly after age 35 and declines sharply after 40. Age 41 is generally considered the point where natural fertility becomes extremely low, and actual menopause typically occurs about 10 years after that substantial drop in conception potential. But “extremely low” is not zero. Spontaneous pregnancies do happen during perimenopause, and when they do, complications are more likely. Irregular cycles make it impossible to predict ovulation reliably, so skipping a period for a month or two doesn’t mean you can’t get pregnant.
Combined Pills for Symptom Relief
Combined oral contraceptives, which contain both estrogen and a progestin, are the most versatile option during perimenopause. They address several problems at once. About 70 to 80 percent of perimenopausal women experience hot flashes and night sweats, and combined pills can help control these vasomotor symptoms. They also regulate the unpredictable cycles that define this life stage, effectively controlling irregular bleeding in roughly 80 percent of cases.
Heavy periods peak in the late 40s, and combined pills reduce menstrual blood loss by approximately 40 percent. Beyond symptom management, long-term use is associated with a significantly reduced risk of ovarian cancer, endometrial cancer, and colorectal cancer. There’s also a bone health benefit: one study of perimenopausal women found that combined pills increased spine bone density by 2.2 percent over 12 months and prevented bone density decline at the hip. Women who started with lower bone density saw the greatest improvement.
Who Should Avoid Combined Pills
The estrogen component of combined pills carries real cardiovascular risks that become more relevant as you get older. Smokers over 35 who smoke more than 15 cigarettes a day should not take combined pills due to a significant increase in blood clot risk. The baseline risk of a venous blood clot rises from 1 to 5 per 10,000 women per year (for non-users) to 3 to 9 per 10,000 for pill users, with the risk climbing further for women over 35 who smoke.
Combined pills are also contraindicated if you have uncontrolled high blood pressure (140/90 or above), a history of blood clots or stroke, migraines with aura, breast or endometrial cancer, certain liver conditions, or known clotting disorders like Factor V Leiden. If you have two or more cardiovascular risk factors, such as older age combined with diabetes, obesity, or smoking, the risks of combined pills outweigh the benefits.
Progestin-Only Options
If estrogen is off the table, progestin-only methods are a safe alternative for most perimenopausal women. These come in several forms: the mini-pill, the hormonal IUD, and the injection.
Progestin-Only Pills
Traditional mini-pills contain lower doses of synthetic progestin than combined pills and work primarily by thickening cervical mucus and altering the uterine lining rather than consistently preventing ovulation. Because fertility naturally declines with age, these pills become increasingly effective in older users. They carry no established association with blood clots, stroke, or heart attack, which makes them suitable for women with obesity, high blood pressure, a history of blood clots, migraines with aura, or diabetes.
The main drawback is unpredictable bleeding. About half of women on traditional mini-pills experience altered bleeding patterns. A newer formulation containing drospirenone offers more consistent ovulation suppression and better bleeding predictability, with higher rates of regular scheduled bleeding and much lower rates of unexpected spotting. The very few contraindications to progestin-only pills include active or recent breast cancer (within the past five years).
One important limitation: while progestin-only methods effectively manage heavy bleeding and provide contraception, they don’t help with hot flashes or protect bone density the way combined pills do.
Hormonal IUD
The levonorgestrel IUD (commonly known by the brand name Mirena) is particularly effective for perimenopausal heavy bleeding. It releases a small, steady dose of progestin directly into the uterus, thinning the uterine lining over time. Studies show it significantly reduces menstrual flow, corrects anemia from chronic blood loss, and improves quality of life scores. Many women using it eventually stop having periods altogether. Because only about 10 percent of the hormone enters the bloodstream, it has almost no effect on ovarian function or systemic hormone levels, making it one of the lowest-risk hormonal options available.
Birth Control Pills vs. Hormone Therapy
Birth control pills and menopausal hormone therapy both contain hormones, but they’re not interchangeable. The estrogen in most birth control pills (ethinyl estradiol) is synthetic and significantly more potent than what’s used in hormone therapy. About two-thirds of pill users take formulations with 30 to 50 micrograms of ethinyl estradiol, while the remaining third take 20-microgram versions. Menopausal hormone therapy uses much lower doses of a different estrogen (conjugated estrogen or estradiol), typically 0.625 milligrams, which provides enough to manage symptoms without the higher-potency contraceptive dose.
During perimenopause, birth control pills are preferred because they suppress ovulation and provide reliable contraception while also managing symptoms. Once menopause is confirmed, the goal shifts from contraception to symptom relief with the lowest effective hormone dose, which is where standard hormone therapy fits in.
How to Know When You’ve Reached Menopause
This is where things get tricky. Hormonal birth control can mask the signs of menopause. Combined pills create a withdrawal bleed during the placebo week that mimics a period, so you can’t use the absence of periods as a guide. The hormonal IUD often causes periods to stop regardless of menopausal status. Even blood tests for FSH (the hormone that rises after menopause) are unreliable while you’re on hormonal contraception. Combined pills suppress FSH to the point where testing during the pill-free interval is considered inaccurate. Injectable contraceptives suppress FSH levels too, and over 40 percent of women on them give inconsistent results on repeated testing.
The general approach is to check FSH levels only in women aged 50 or older, and ideally after stopping hormonal methods for at least two weeks. Because a single test can be misleading, confirmation typically requires two consecutively elevated FSH readings. Without hormonal methods in the picture, the standard definition applies: no period for one year after age 50, or no period for two years before age 50.
Transitioning From Birth Control to Hormone Therapy
If you’ve been taking combined pills through perimenopause and want to move to hormone therapy, the transition usually happens around age 50 to 55. Your provider will help you stop the pill, check whether menopause has occurred (using FSH testing or by observing whether periods return), and then start hormone therapy at the lower menopausal dose if symptoms warrant it. Some women find that stopping the pill reveals symptoms they didn’t know they had, since the pill was already managing hot flashes and sleep disruption. Others discover they’ve already passed through menopause without realizing it, because the pill’s withdrawal bleeds continued on schedule.
If you’ve been using a progestin-only method like the hormonal IUD, the transition looks a bit different. The IUD can actually stay in place while estrogen therapy is added, essentially becoming the progestin component of a combined hormone therapy regimen. This is a practical option for women who are already happy with their IUD and want seamless symptom management through the transition.